FDA approves Nufymco as biosimilar to Lucentis
By: Anthony DeFino Fact checked by: Eamon N. Dreisbach Key takeaways: Nufymco is indicated for the treatment of patients with a number of retinal diseases. The VEGF inhibitor is the…
Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions
Click Here To Save Now